Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Exagen Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
XGN
Nasdaq
3840
www.exagen.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Exagen Inc.
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
- May 9th, 2025 2:05 pm
Exagen First Quarter 2025 Earnings: Beats Expectations
- May 8th, 2025 7:18 am
Exagen Inc. Prices Public Offering of Common Stock
- May 8th, 2025 6:30 am
Exagen Inc. Announces Proposed Public Offering of Common Stock
- May 7th, 2025 2:05 pm
Exagen Inc (XGN) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Wins Amidst ...
- May 6th, 2025 1:03 am
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates
- May 5th, 2025 7:10 am
Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume
- May 5th, 2025 6:00 am
Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors
- Apr 28th, 2025 7:00 am
Institutional investors control 30% of Exagen Inc. (NASDAQ:XGN) and were rewarded last week after stock increased 30%
- Apr 25th, 2025 4:40 am
Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025
- Apr 21st, 2025 2:05 pm
SurgePays And 2 Other Promising Penny Stocks To Watch
- Mar 27th, 2025 5:04 am
Exagen Inc. (NASDAQ:XGN) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
- Mar 14th, 2025 4:43 am
Exagen Full Year 2024 Earnings: EPS Beats Expectations
- Mar 12th, 2025 4:31 am
Exagen Inc (XGN) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives
- Mar 12th, 2025 1:04 am
Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates
- Mar 11th, 2025 7:15 am
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights
- Mar 11th, 2025 6:00 am
Investors in Exagen (NASDAQ:XGN) have unfortunately lost 84% over the last five years
- Mar 2nd, 2025 5:17 am
Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025
- Feb 25th, 2025 2:05 pm
Strength Seen in Exagen (XGN): Can Its 29.4% Jump Turn into More Strength?
- Feb 5th, 2025 4:38 am
Exagen Inc. to Participate in Upcoming Investor Conferences
- Feb 4th, 2025 2:05 pm
Scroll